~~<i id='C548C2C73F'><strike id='C548C2C73F'><tt id='C548C2C73F'><pre id='C548C2C73F'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

explore

author：hotspot 2025-10-02 19:39:00 - browse：9616

Powdered ibogaine against a white background. — Tabernanthe iboga, the shrub that contains the psychedelic substance ibogaine. Wikimedia Commons

The psychedelic ibogaine is unlikely to ever receive approval as a treatment for opioid addiction, the federal government’s top addiction researcher said Thursday.

The remarks from Nora Volkow, the longtime director of the National Institute on Drug Abuse, serve as a cautionary note amid widespread enthusiasm about ibogaine, a naturally occurring substance that drug companies and researchers have increasingly cast as a potential paradigm-shifting addiction treatment.

But its potential cardiac side effects could stand in the way of receiving approval from the Food and Drug Administration, Volkow said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： As Taiwan prepares for anti

explore

hotspot

Wikipedia

hotspot

knowledge

hotspot

SusanGalbraith,AstraZeneca’sheadofcancerresearchanddevelopment,speaksataSTATeventin2023.MarieMillerf

WSS

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

Court strikes down limits on filming of police in Arizona

7 of the most gruesome medical devices in history

Shifting the focus from loneliness to social health

Change Healthcare can notify patients about the breach, HHS says

Death toll from an explosion and collapse of a Paris building in June climbs to 3

focus

explore

explore

Peter Hotez and the public health issue of online harassment

New rules on organ donation and transplantation 'will bring chaos'

Sports medicine is finally prioritizing gender equality

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Ionis drug prevents swelling attacks due to hereditary angioedema

Trump demands the U.S. pay no more for drugs than other countries … again

Death toll from an explosion and collapse of a Paris building in June climbs to 3

Hepatitis C has a cure — but many Americans still lack access to it

In new study, freeze

hotspot

How to increase colonoscopy rates? Looks like an AI can help

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

In new study, freeze

Court strikes down limits on filming of police in Arizona

New rules on organ donation and transplantation 'will bring chaos'

How to increase colonoscopy rates? Looks like an AI can help

Wikipedia

hotspot

knowledge

hotspot